Zanubrutinib in Primary Cold Agglutinin Disease
NCT06067048
·
clinicaltrials.gov ↗
PHASE2
Phase
ACTIVE_NOT_RECRUITING
Status
25
Enrollment
OTHER
Sponsor class
Conditions
Lymphoma
Interventions
DRUG:
Zanubrutinib Oral Capsule
Sponsor
Stichting Hemato-Oncologie voor Volwassenen Nederland